Latest filing published 31 Jul 2026 for Iqvia Holdings INC., €994k.
Ari Bousbib filed 96 disclosures between January 5, 2016 and July 31, 2026: 90 at Iqvia Holdings Inc. and 6 at IMS Health Holdings, Inc., with the title "See Remarks" in both cases. The 30 sales total EUR 224.6 million, median EUR 5,666,561, high amounts per trade. The largest are from July 26, 2018 (EUR 38,656,285), June 2, 2020 (EUR 22,118,795) and June 28, 2019 (EUR 13,505,741). No purchase.
The record also holds 53 grants, 8 other filings and 5 option exercises. 2020 has 17 filings, 2025 has 16 and 2017 has 11; the trough is 2022 with 3. 20 filings fall in the last twelve months, 11 of them sales. The median publication delay is 2 days.
At Iqvia, 12 of Ari Bousbib's own market trades fall within 30 days of trades by Eric Sherbet, 10 within 30 days of TPG Group Holdings (SBS) Advisors, Inc., 9 within 30 days of W. Richard Staub and 8 within 30 days of John Connaughton, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 96 declarations